The endothelin receptor: A novel target for anticancer therapy

American Journal of Cancer

Volumn 1, Issue 2, 2002, Pages 81-91

  Pirtskhalaishvili, Georgi ^a   Nelson, Joel B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; 3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; 3 BENZYL 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 2 BUTENOIC ACID; 4 (1,3 BENZODIOXOL 5 YL) 1 [(2,6 DIETHYLPHENYL)CARBAMOYLMETHYL] 2 (4 PROPOXYPHENYL) 3 PYRROLIDINECARBOXYLIC ACID; 4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; 4 TERT BUTYL N [6 (2 HYDROXYETHOXY) 5 (3 METHOXYPHENOXY) 4 PYRIMIDINYL]BENZENESULFONAMIDE; ALPHA [[1 BUTYL 5 [2 [(2 CARBOXYPHENYL)METHOXY] 4 METHOXYPHENYL] 1H PYRAZOL 4 YL]METHYLENE] 6 METHOXY 1,3 BENZODIOXOLE 5 PROPANOIC ACID; ATRASENTAN; BMS 18287; BOSENTAN; BQ 610; CP 170687; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOSPORIN; DARUSENTAN; DOXORUBICIN; ENDOTHELIN 1 [11-21]; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ENRASENTAN; INTERLEUKIN 1BETA; L 751281; L 754142; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N (HEXAHYDRO 1 AZEPINYLCARBONYL)LEUCYL(1 METHYL DEXTRO TRYPTOPHYL) DEXTRO TYROSINE; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; N ACETYL 3,3 DIPHENYL DEXTRO ALANYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; PERHYDRO 1 AZEPINYLCARBONYLLEUCYL DEXTRO TRYPTOPHYL DEXTRO TRYPTOPHAN; RES 7013; TAK 044; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; BONE CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; COLON CANCER; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG TARGETING; GENETIC ANALYSIS; HEADACHE; HUMAN; KAPOSI SARCOMA; KIDNEY CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NONHUMAN; OVARY CANCER; PAIN; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW; RHINITIS; SEQUENCE ANALYSIS; UTERINE CERVIX CANCER;

EID: 0013084674     PISSN: 11756357     EISSN: None     Source Type: Journal    
DOI: 10.2165/00024669-200201020-00001     Document Type: Review

References (114)

1. Yanagisawa M, Inoue A, Ishikawa T, et al. Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci USA 1988; 85 (18): 6964-7
2. Bloch KD, Friedrich SP, Lee ME, et al. Structural organization and chromosomal assignment of the gene encoding endothelin. J Biol Chem 1989; 264 (18): 10851-7
3. Bloch KD, Eddy RL, Shows TB, et al. cDNA cloning and chromosomal assignment of the gene encoding endothelin 3. J Biol Chem 1989; 264 (30): 18156-61
4. Bloch KD, Hong CC, Eddy RL, et al. cDNA cloning and chromosomal assignment of the endothelin 2 gene: vasoactive intestinal contractor peptide is rat endothelin 2. Genomics 1991; 10 (1): 236-42
5. Springall DR, Howarth PH, Counihan H, et al. Endothelin immunoreactivity of airway epithelium in asthmatic patients. Lancet 1991; 337 (8743): 697-701
6. Marsh MM, Findlay JK, Salamonsen LA. Endothelin and menstruation. Hum Reprod 1996; 11 Suppl. 2: 83-9
7. Langenstroer P, Tang R, Shapiro E, et al. Endothelin-1 in the human prostate: tissue levels, source of production and isomETic tension studies. J Urol 1993; 150 (2 Pt 1): 495-9
8. Ishikawa T, Yanagisawa M, Kimura S, et al. Positive inotropic action of novel vasoconstrictor peptide endothelin on guinea pig atria. Am J Physiol 1988; 255 (4 Pt 2): H970-3
9. Uchida Y, Ninomiya H, Saotome M, et al. Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. Eur J Pharmacol 1988; 154 (2): 227-8
10. Lopez-Farre A, Montanes I, Millas I, et al. Effect of endothelin on renal function in rats. Eur J Pharmacol 1989; 163 (1): 187-9
11. Stojilkovic SS, Merelli F, Iida T, et al. Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior pituitary cells. Science 1990; 248 (4963): 1663-6
12. Lin WW, Lee CY. Biphasic effects of endothelin in the guinea-pig ileum. Eur J Pharmacol 1990; 176 (1): 57-62
13. Maggi CA, Giuliani S, Patacchini R, et al. Potent contractile activity of endothelin on the human isolated urinary bladder. Br J Pharmacol 1989; 96 (4): 755-71
14. Inoue A, Yanagisawa M, Takuwa Y, et al. The human preproendothelin-1 gene. Complete nucleotide sequence and regulation of expression. J Biol Chem 1989; 264 (25): 14954-9
15. Kurihara H, Yoshizumi M, Sugiyama T, et al. The possible role of endothelin-1 in the pathogenesis of coronary vasospasm [discussion]. J Cardiovasc Pharmacol 1989; 13 Suppl. 5: S132-7; discussion S42
16. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989; 161 (3): 1220-7
17. Matsumoto H, Suzuki N, Shiota K, et al. Insulin-like growth factor-I stimulates endothelin-3 secretion from rat anterior pituitary cells in primary culture. Biochem Biophys Res Commun 1990; 172 (2): 661-8
18. Kanse SM, Takahashi K, Warren JB, et al. Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. Eur J Pharmacol 1991; 199 (1): 99-101
19. Kanse SM, Takahashi K, Lam HC, et al. Cytokine stimulated endothelin release from endothelial cells. Life Sci 1991; 48 (14): 1379-84
20. Ito H, Hirata Y, Adachi S, et al. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 1993; 92 (1): 398-403
21. Hu RM, Levin ER, Pedram A, et al. Insulin stimulates production and secretion of endothelin from bovine endothelial cells. Diabetes 1993; 42 (2): 351-8
22. Schluter KD, Piper HM. Regulation of growth in the adult cardiomyocytes. FASEB J 1999; 13: S17-22
23. Burnstock G. Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat 1999; 194 (Pt 3): 335-42
24. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 1990; 85 (2): 587-90
25. Prins BA, Hu RM, Nazario B, et al. Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells. J Biol Chem 1994; 269 (16): 11938-44
26. Kanse SM, Takahashi K, Warren JB, et al. Production of endothelin by vascular smooth muscle cells. J Cardiovasc Pharmacol 1991; 17 Suppl. 7: S113-6
27. Hanehira T, Kohno M, Yoshikawa J. Endothelin production in cultured vascular smooth muscle cells - modulation by the atrial, brain, and C-type natriuretic peptide system. Metabolism 1997; 46 (5): 487-93
28. Xu D, Emoto N, Giaid A, et al. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 1994; 78 (3): 473-85
29. Vijayaraghavan J, Scicli AG, Carretero OA, et al. The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem 1990; 265 (24): 14150-5
30. Arai H, Hori S, Aramori I, et al. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348 (6303): 730-2
31. Sakurai T, Yanagisawa M, Takuwa Y, et al. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 1990; 348 (6303): 732-5
32. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992; 13 (3): 103-8
33. Clozel M, Loffler BM, Breu V, et al. Downregulation of endothelin receptors by autocrine production of endothelin-1. Am J Physiol 1993; 265 (1 Pt 1): C188-92
34. Nambi P, Wu HL, Lipshutz D, et al. Identification and characterization of endothelin receptors on rat osteoblastic osteosarcoma cells: down-regulation by 1,25-dihydroxy-vitamin D3. Mol Pharmacol 1995; 47 (2): 266-71
35. Liu J, Chen R, Casley DJ, et al. Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes. Am J Physiol 1990; 258 (3 Pt 2): H829-35
36. Nambi P, Pullen M, Contino LC, et al. Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur J Pharmacol 1990; 187 (1): 113-6
37. Newman P, Kakkar VV, Kanse SM. Modulation of endothelin receptor expression in human vascular smooth muscle cells by interleukin-1 beta. FEBS Lett 1995; 363 (1-2): 161-4
38. Schiffrin EL, Touyz RM. Vascular biology of endothelin. J Cardiovasc Pharmacol 1998; 32 Suppl. 3: S2-13
39. Battistini B, D'Orleans-Juste P, Sirois P. Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest 1993; 68 (6): 600-28
40. de Nucci G, Thomas R, D'Orleans-Juste P, et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85 (24): 9797-800
41. Yoshimoto S, Ishizaki Y, Sasaki T, et al. Effect of carbon dioxide and oxygen on endothelin production by cultured porcine cerebral endothelial cells. Stroke 1991; 22 (3): 378-83
42. Hafizi S, Allen SP, Goodwin AT, et al. Endothelin-1 stimulates proliferation of human coronary smooth muscle cells via the ET(A) receptor and is co-mitogenic with growth factors. Atherosclerosis 1999; 146 (2): 351-9
43. Kurihara Y, Kurihara R, Suzuki H, et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 [comment]. Nature 1994; 368 (6473): 703-10
44. Baynash AG, Hosoda K, Giaid A, et al. Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994; 79 (7): 1277-85
45. Hosoda K, Hammer RE, Richardson JA, et al. Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 1994; 79 (7): 1267-76
46. Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell 1994: 79 (7): 1257-66
47. Kusuhara M, Yamaguchi K, Nagasaki K, et al. Production of endothelin in human cancer cell lines. Cancer Res 1990; 50 (11): 3257-61
48. Yanagisawa M, Masaki T. Endothelin, a novel endothelium-derived peptide. Pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 1989; 38 (12): 1877-83
49. Nelson JB, Chan-Tack K, Hedican SP, et al. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 1996; 56 (4): 663-8
50. Wu-Wong JR, Chiou WJ, Dickinson R, et al. Endothelin attenuates apoptosis in human smooth muscle cells. Biochem J 1997; 328 (Pt 3): 733-7
51. Moraitis S, Langdon SP, Miller WR. Endothelin expression and responsiveness in human ovarian carcinoma cell lines. Eur J Cancer 1997; 33 (4): 661-8
52. Yohn JJ, Smith C, Stevens T, et al. Human melanoma cells express functional endothelin-1 receptors. Biochem Biophys Res Commun 1994: 201 (1): 449-57
53. Shichiri M, Kato H, Marumo F, et al. Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells [published erratum appears in Hypertension 1998 Feb; 31 (2): 723]. Hypertension 1997; 30 (5): 1198-203
54. Battistini B, Chailler P, D'Orleans-Juste P, et al. Growth regulatory properties of endothelins. Peptides 1993; 14 (2): 385-99
55. Miyakawa M, Tsushima T, Isozaki O, et al. Endothelin-1 stimulates c-fos mRNA expression and acts as a modulator on cell proliferation of rat FRTL5 thyroid cells. Biochem Biophys Res Commun 1992; 184 (1): 231-8
56. Salamonsen LA, Young RJ, Garcia S, et al. Mitogenic actions of endothelin and other growth factors in ovine endomETium. J Endocrinol 1997; 152 (2): 283-90
57. Pagotto U, Arzberger T, Hopfner U, et al. Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth. J Clin Invest 1995; 96 (4): 2017-25
58. Bagnato A, Rosano L, Di Castro V, et al. Endothelin receptor blockade inhibits proliferation of Kaposi's sarcoma cells. Am J Pathol 2001; 158 (3): 841-7
59. Eberl LP, Egidy G, Pinet F, et al. Endothelin receptor blockade potentiates FasL-induced apoptosis in colon carcinoma cells via the protein kinase C-pathway. J Cardiovasc Pharmacol 2000; 36 (5 Suppl. 1): S354-6
60. Eberl LP, Valdenaire O, Saintgiorgio V, et al. Endothelin receptor blockade potentiates FasL-induced apoptosis in rat colon carcinoma cells. Int J Cancer 2000; 86 (2): 182-7
61. Masaki T, Miwa S, Sawamura T, et al. Subcellular mechanisms of endothelin action in vascular system. Eur J Pharmacol 1999; 375 (1-3): 133-8
62. Koh E, Morimoto S, Kim S, et al. Endothelin stimulates Na+/H+ exchange in vascular smooth muscle cells. Biochem Int 1990; 20 (2): 375-80
63. Aramori I, Nakanishi S. Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells. J Biol Chem 1992; 267 (18): 12468-74
64. Lissoni P, Malugani F, Bonfanti A, et al. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. J Biol Regul Homeost Agents 2001; 15 (2): 140-4
65. Salani D, Di Castro V, Nicotra MR, et al. Role of endothelin-1 in neovascularization of ovarian carcinoma. Am J Pathol 2000; 157 (5): 1537-47
66. Yamashita J, Ogawa M, Shirakusa T. Plasma endothelin-1 as a marker for doxorubicin cardiotoxicity. Int J Cancer 1995; 62 (5): 542-7
67. Nelson JB, Hedican SP, George DJ, et al. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1995; 1 (9): 944-99
68. Gohji K, Kitazawa S, Tamada H, et al. Expression of endothelin receptor a associated with prostate cancer progression. J Urol 2001; 165 (3): 1033-6
69. Nelson JB, Lee WH, Nguyen SH, et al. Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res 1997; 57 (1): 35-7
70. Nelson JB, Carducci MA, Dawson M, et al. Preliminary phase II results using ABT-627, an endothelin-A selective receptor antagonist, in men with symptomatic hormone refractory prostate cancer [abstract]. In: AUA 95th Annual Meeting. 2000 Apr 29-May 4; Atlanta (Ga). J Urol 2000; 163: 159
71. Nelson JB, Carducci MA, Zonnenberg B, et al. The endothelin-A receptor antagonist atrasentan improves time to clinical progression in hormone refractory prostate cancer patients: a randomized, double-blind, multi-national study [abstract]. In: AUA 96th Annual Meeting. 2001 Jun 2-7: Anaheim (Ca). J Urol 2001; 165 Suppl.: 168
72. Carducci MA, Nelson JB, Padley RJ, et al. The endothelin-A receptor antagonist atrasentan (ABT-627) delays clinical progression in hormone refractory prostate cancer: a multinational, randomized, double-Blind, placebo-controlled trial [abstract no. 694]. Proceedings of the American Society of Clinical Oncology (ASCO) 37th Annual Meeting; 2001 May 12-15; San Francisco.
73. Bagnato A, Salani D, Di Castro V, et al. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth. Cancer Res 1999; 59 (3): 720-7
74. Moraitis S, Miller WR, Smyth JF, et al. Paracrine regulation of ovarian cancer by endothelin. Eur J Cancer 1999; 35 (9): 1381-7
75. Kikuchi K, Nakagawa H, Kadono T, et al. Decreased ET(B) receptor expression in human metastatic melanoma cells. Biochem Biophys Res Commun 1996; 219 (3): 734-9
76. Eberle J, Weitmann S, Thieck O, et al. Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes. J Invest Dermatol 1999; 112 (6): 925-32
77. Demunter A, De Wolf-Peeters C, Degreef H, et al. Expression of the endothelin-B receptor in pigment cell lesions of the skin. Evidence for its role as tumor progression marker in malignant melanoma. Virchows Arch 2001; 438 (5): 485-91
78. Lahav R, Heffner G, Patterson PH. An endothelin receptor B antagonist inhibits growth and induces cell death in human melanoma cells in vitro and in vivo. Proc Natl Acad Sci USA 1999; 96 (20): 11496-500
79. Nelson JB, Nguyen SH, Wu-Wong JR, et al. New bone formation in an osteoblastic tumor model is increased by endothelin-1 overexpression and decreased by endothelin A receptor blockade. Urology 1999; 53 (5): 1063-9
80. Nelson JB, Carducci MA, Padley RJ, et al. The endothelin-A receptor antagonist atrasentan (ABT-627) reduces skeletal remodeling activity in men with advanced, hormone refractory prostate cancer [abstract no. 12]. Proceedings of the American Society of Clinical Oncology (ASCO) 37th Annual Meeting. 2001 May 12-15; San Francisco.
81. Yamashita J, Ogawa M, Inada K, et al. A large amount of endothelin-1 is present in human breast cancer tissues. Res Commun Chem Pathol Pharmacol 1991; 74 (3): 363-9
82. Lu J, Liang Y, Wang X. Immuno histochemical study of endothelin-1 in breast cancer [in Chinese]. Chin J Oncol 1995; 17 (1): 13-5
83. Alanen K, Deng DX, Chakrabarti S. Augmented expression of endothelin-1, endothelin-3 and the endothelin-B receptor in breast carcinoma. Histopathology 2000; 36 (2): 161-7
84. Zheng H, Bflug BR, Marshall FF, et al. Frequent promoter methilation of the endothetin B receptor gene in the human renal tumors [abstract]. In: AUA 94th Annual Meeting; 1999 May 1-6; Dallas (TX). J Urol. 1999; 161 Suppl.: 137
85. Thevarajah S, Udan MS, Zheng H, et al. Endothelin axis expression in renal carcinoma. In: AUA 94th Annual Meeting; 1999 May 1-6; Dallas (TX). J Urol. 1999; 161 Suppl.: 137
86. Giaid A, Hamid QA, Springall DR, et al. Detection of endothelin immunoreactivity and mRNA in pulmonary tumours. J Pathol 1990; 162 (1): 15-22
87. Ahmed SI, Thompson J, Coulson JM, et al. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol 2000; 22 (4): 422-31
88. Egidy G, Juillerat-Jeanneret L, Jeannin JF, et al. Modulation of human colon tumor-stromal interactions by the endothelin system. Am J Pathol 2000; 157 (6): 1863-74
89. Venuti A, Salani D, Manni V, et al. Expression of endothelin 1 and endothelin A receptor in HPV-associated cervical carcinoma: new potential targets for anticancer therapy. FASEB J 2000; 14 (14): 2277-83
90. Harland SP, Kuc RE, Pickard JD, et al. Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery 1998; 43 (4): 890-8; discussion 8-9
91. Pagotto U, Arzberger T, Hopfner U, et al. Cellular localization of endothelin receptor mRNAs (ETA and ETB) in brain tumors and normal human brain. J Cardiovasc Pharmacol 1995; 26 Suppl. 3: S104-6
92. Walden PD, Ittmann M, Monaco ME, et al. Endothelin-1 production and agonist activities in cultured prostate-derived cells: implications for regulation of endothelin bioactivity and bioavailability in prostatic hyperplasia. Prostate 1998; 34 (4): 241-50
93. Kobayashi S, Tang R, Wang B, et al. Localization of endothelin receptors in the human prostate. J Urol 1994; 151 (3): 763-6
94. Le Brun G, Moldovan F, Aubin P, et al. Identification of endothelin receptors in normal and hyperplasic human prostate tissues. Prostate 1996; 28 (6): 379-84
95. Le Brun G, Aubin P, Soliman H, et al. Upregulation of endothelin 1 and its precursor by IL-1beta. TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line. Cytokine 1999; 11 (2): 157-62
96. Takuwa Y, Masaki T, Yamashita K. The effects of the endothelin family peptides on cultured osteoblastic cells from rat calvariae. Biochem Biophys Res Commun 1990; 170 (3): 998-1005
97. Shioide M, Noda M. Endothelin modulates osteopontin and osteocalcin messenger ribonucleic acid expression in rat osteoblastic osteosarcoma cells. J Cell Biochem 1993; 53 (2): 176-80
98. Alam AS, Gallagher A, Shankar V, et al. Endothelin inhibits osteoclastic bone resorption by a direct effect on cell motility: implications for the vascular control of bone resorption. Endocrinology 1992; 130 (6): 3617-24
99. Koeneman KS, Yeung F, Chung LW. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate 1999; 39 (4): 246-61
100. Bagnato A, Tecce R, Moretti C, et al. Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells. Clin Cancer Res 1995; 1 (9): 1059-66
101. Vacca F, Bagnato A, Catt KJ, et al. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells. Cancer Res 2000; 60 (18): 5310-7
102. Sasaki T, Hong MH. Endothelin-1 localization in bone cells and vascular endothelial cells in rat bone marrow. Anat Rec 1993; 237 (3): 332-7
103. Semler DE, Morris DL, Stern PH. Endothelin-stimulated Ca(2+)signaling and endothelin receptor expression are decreased by parathyroid hormone treatment in UMR-106 osteoblastic osteosarcoma cells. Cell Calcium 2000; 28 (1): 55-64
104. Pupilli C, Brunori M, Misciglia N, et al. Presence and distribution of endothelin-1 gene expression in human kidney. Am J Physiol 1994; 267 (4 Pt 2): F679-87
105. Ohkubo S, Ogi K, Hosoya M, et al. Specific expression of human endothelin-2 (ET-2) gene in a renal adenocarcinoma cell line. Molecular cloning of cDNA encoding the precursor of ET-2 and its characterization. FEBS Lett 1990; 274 (1-2): 136-40
106. Pflug BR, Udan MS, Zheng H, et al. Endothelin-1 inhibits paclitaxel-induced apoptosis in renal cell carcinoma through Akt activation. In: AUA 95th General Meeting; 2000 Apr 29-May 4; Atlanta (GA). J Urol. 2000; 163 Suppl.: 159
107. Oikawa T, Kushuhara M, Ishikawa S, et al. Production of endothelin-1 and thrombomodulin by human pancreatic cancer cells. Br J Cancer 1994; 69 (6): 1059-64
108. Kitagawa N, Tsutsumi K, Niwa M, et al. A selective endothelin ETA antagonist, BQ-123, inhibits 125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells. Cell Mol Neurobiol 1994; 14 (2): 105-18
109. Dahlof B, Gustafsson D, Hedner T, et al. Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reaction. J Hypertens 1990; 8 (9): 811-7
110. Raffa RB, Schupsky JJ, Martinez RP, et al. Endothelin-1-induced nociception. Life Sci 1991; 49 (11): L61-5
111. Pomonis JD, Rogers SD, Peters CM, et al. Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception. J Neurosci 2001; 21 (3): 999-1006
112. Gokin AP, Fareed MU, Pan HL, et al. Local injection of endothelin-1 produces pain-like behavior and excitation of nociceptors in rats. J Neurosci 2001; 21 (14): 5358-66
113. Griswold DE, Douglas SA, Martin LD, et al. Targeted disruption of the endothelin-B-receptor gene attenuates inflammatory nociception and cutaneous inflammation in mice. J Cardiovasc Pharmacol 2000; 36 (5 Suppl. 1): S78-81
114. Janig W. Neurophysiological mechanisms of cancer pain. Recent Results Cancer Res 1984; 89: 45-58